Can common diabetes drug help reverse mouth scarring?

NCT ID NCT06871904

First seen Dec 24, 2025 · Last updated May 01, 2026 · Updated 22 times

Summary

This study tested whether metformin (a diabetes drug) and pirfenidone (an anti-scarring drug) can reduce fibrosis in people with oral submucous fibrosis, a condition that causes mouth stiffness and raises cancer risk. 45 adults with limited mouth opening received either the drugs or a placebo. Researchers measured changes in mouth opening, pain, and molecular markers to see if these affordable treatments could improve symptoms and prevent disease progression.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORAL SUBMUCOUS FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Ziauddin University

    Karachi, Sindh, 74700, Pakistan

Conditions

Explore the condition pages connected to this study.